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1. Introduction
Surgery, as we know it today, could not have developed without the
major achievements in immunobiology that have occurred during
the last 150 years. Because of the relationship of immunobiology
to transfusions, transplantation, wound healing, infection, cancer
therapy and drug therapy, immunobiologic principles are employed
in the treatment of virtually every surgical patient. It is the purpose
of this paper to brieﬂy review the early contributions that Dr. Renzo
Dionigi made to this important ﬁeld.
Dr. Dionigi had his basic surgical training at the University of Pavia,
then he came to Cincinnati in 1968 to work in the department of
surgery with Dr. William A. Altemeier. He was promptly assigned
to work in my laboratory where he did an outstanding job during
the next two years, with major contributions in the ﬁeld of
immunobiology.
2. Early contributions of Renzo Dionigi at the University of
Cincinnati 1968–1970
2.1. Hepatic transplantation
One of the ﬁrst interests of Dr. Dionigi was to develop better
techniques for auxiliary liver transplantation. His initial work was
hampered by a high incidence of out-ﬂow block, which demonstrated
a self-perpetuating injury to the liver caused by restriction of portal
ﬂow. He reasoned that this was related to the effects of histamine and
developed the use of diphenhydramine hydrochloride (Benadryl®)
which he added to the perfusate used for ﬂushing the liver prior
to transplantation. This advancement provided a major contribution
to the study of auxiliary liver transplantation. 1 Subsequent studies
in 28 mongrel dogs allowed the development of better techniques
for auxiliary liver transplantation, which subsequently aided in the
development of cellular hepatic liver transplants and modiﬁcation of
techniques for human hepatic transplant. 2
2.2. Antilymphocyte globulin (ALG)
Concurrent with the development of hepatic transplant techniques,
Dr. Dionigi performed sentinel experiments in the preparation and
use of ALG. Our clinical team became committed to the clinical
use of ALG, but the possibility of making ALG using horses became
untenable for a variety of reasons. Thus, we decided to develop
products for human use in goats and rabbits, which were more
readily available and provided high titer antibody. For initial clinical
use, goats were used for immunization and preparation of the ALG
because of their larger size and the ease of care in our facility.
Standard techniques were used for immunization and preparation of
the gamma globulin product for treatment of patients. ALGwasmade
from animals treated with either human splenocytes (ASLG), or
thymocytes (ATLG). In an initial analysis of the ﬁrst ten patients
treated, only one organwas lost (a cadaveric kidney) from hyperacute
rejection. In another transplant patient, there was a documented
rejection episode eight days after transplantation. ASLG was used
successfully to control rejection episodes. Dr. Dionigi analyzed the
use of both ATLG and ASLG by examining lymph node biopsies,
concluding that lymphocytes in thymic dependent areas were
decreased with either product, but lymphocytes in germinal centers
and other B-cell dependent areas were affected primarily by ASLG. 3
The initial observations with the biological effects of type-speciﬁc
anti-lymphocyte globulin led Dr. Dionigi to study the effects of
potentiation of various immunosuppressive agents on the effects of
ATLG in a canine renal allotransplant model. Hewas able to show that
the effects on the depletion of T-lymphocytes were accentuated by
both cyclophosphamide and methylprednisolone, with the greatest
effects in thymic dependent areas of spleen and lymph nodes. 4
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Finally, in a series of canine experiments, he showed that different
types of ALG (using B-cell lymphocytes compared to T-cell lympho-
cytes for immunization) were associated with different degrees of
depletion of lymphocytes in thymic dependent and gut dependent
areas. Greater than 90% depletion of cells in thymic dependent areas
had a greater effect on decreasing cell-mediated immune responses
compared to antibody responses whereas the percent of depletion
of cells in gut dependent areas greater than 90% was associated
with reduced antibody responses to an antigenic stimulus. 5 These
studies have been a stimulus for the development of more speciﬁc
antilymphocyte antibodies basedupon speciﬁc antigens (such as anti-
CD3 antilymphocyte globulin).
2.3. Immunobiology of infection
The next area where Dr. Dionigi made major contributions to
immunobiology while in Cincinnati was related to non-speciﬁc host
defense mechanisms, namely the role of neutrophils in host defense
against infections, especially related to burn injury and transplan-
tation. 6 A test of the antibacterial function of neutrophils was
used to simultaneously study the ability of neutrophils to kill
Staphylococcus aureus in nine normal human volunteers. He was able
to demonstrate that there was a periodic dysfunction of neutrophils
occurring at approximately two- to three-week intervals. A signiﬁcant
infection (multiple furuncles) occurred in one of these individuals
at a time when neutrophil function was particularly poor. The same
kind of periodic dysfunction was observed in patients receiving
immunosuppressive drugs for renal transplantation, but the defects
were much worse. Like normal individuals, some of these patients
were studied for a long period of time (up to 6 months) and showed
evidence of a much longer cycle of about two months. Studies in
burn patients were not dissimilar with periods of extreme dysfunc-
tion in neutrophils which was associated with the development of
sepsis. These periodic variations and abnormalities in neutrophil
functionwere also studied in several laboratory animal species. It was
shown that removal of the gonads and adrenal glands did not prevent
the cyclic variation in neutrophil function. The abnormal antibacterial
function of neutrophils was demonstrated to occur at least in part
because of nutritional deﬁciencies, mostly related to deﬁciencies in
protein metabolism. Dr. Dionigi subsequently brought one of his
colleagues, Dr. Lorenzo Dominioni, to Cincinnati who made major
contributions to the ﬁeld of nutrition, particularly demonstrating the
beneﬁcial effects of early nutrition and composition of the diet in
subjects with burn injury.
3. Conclusion
Upon returning to Pavia and to the University of Insubria, Dr. Dionigi
has continued to make major contributions to the practice of
immunobiology in the ﬁelds of transplantation, nutrition, infection,
and cancer.
He himself acted like an aggressive antibody, attaching to his
favorite antigen, Janet Hasselbrock who he met during his stay
in Cincinnati. They have had three immunocompetent products,
Adrianna, Gianlorenzo, and Marta. We all owe a great deal of
gratitude to the many contributions of Professor Dionigi to the ﬁeld
of immunobiology.
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